Vitae Pharmaceuticals Inc (VTAE)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Vitae Pharmaceuticals Inc (VTAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013252
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vitae Pharmaceuticals Inc (Vitae Pharmaceuticals) is a biopharmaceutical company that offers pharmaceutical products. The company discovers and develops and small molecule drugs for diseases with significant unmet medical needs. Its products pipeline includes VTP-34072, BI 1147560, VTP-43742, VTP-38543 and VTP-38443. Vitae Pharmaceuticals’ products address therapeutic areas such as diabetes, Alzheimer’s disease, atopic dermatitis, autoimmune disorders, and acute coronary syndrome. The company utilizes its contour structure-based drug design platform to discover and develop product candidates for validated therapeutic targets. It operates through biotechnology companies for the treatment of metabolic diseases. The company provides services to healthcare sector. Vitae Pharmaceuticals is headquartered in Fort Washington, Pennsylvania, the US.

Vitae Pharmaceuticals Inc (VTAE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Syndax Pharma Enters into Licensing Agreement with Vitae Pharma 11
Equity Offering 13
Vitae Pharma Raises USD35 Million in Public Offering of Shares 13
Vitae Pharma Raises USD41 Million in Public Offering of Shares 15
Vitae Pharmaceuticals Completes Exercise of Underwriter’s Over Allotment Option for IPO for USD63.3 Million 17
Acquisition 19
Allergan Acquires Vitae Pharma in Tender Offer 19
Vitae Pharmaceuticals Inc – Key Competitors 21
Vitae Pharmaceuticals Inc – Key Employees 22
Vitae Pharmaceuticals Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Aug 03, 2016: Vitae Pharmaceuticals Reports Second Quarter 2016 Operating and Financial Results 24
May 10, 2016: Vitae Pharmaceuticals Reports First Quarter 2016 Operating and Financial Results 26
Mar 03, 2016: Vitae Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Operating and Financial Results 28
Corporate Communications 30
Jul 27, 2016: Vitae Pharmaceuticals Appoints Daniel M. Junius to Board of Directors 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vitae Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Vitae Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Syndax Pharma Enters into Licensing Agreement with Vitae Pharma 11
Vitae Pharma Raises USD35 Million in Public Offering of Shares 13
Vitae Pharma Raises USD41 Million in Public Offering of Shares 15
Vitae Pharmaceuticals Completes Exercise of Underwriter's Over Allotment Option for IPO for USD63.3 Million 17
Allergan Acquires Vitae Pharma in Tender Offer 19
Vitae Pharmaceuticals Inc, Key Competitors 21
Vitae Pharmaceuticals Inc, Key Employees 22

★海外企業調査レポート[Vitae Pharmaceuticals Inc (VTAE)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Telos Corporation:企業の戦略・SWOT・財務情報
    Telos Corporation - Strategy, SWOT and Corporate Finance Report Summary Telos Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Orchid Pharma Ltd (ORCHIDPHAR):企業の財務・戦略的SWOT分析
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • Amedisys Inc (AMED)-製薬・医療分野:企業M&A・提携分析
    Summary Amedisys Inc (Amedisys) is a healthcare company that offers home health care, hospice service and personal care. The company provides practical nursing services and occupational therapy, comfort and support services for those are facing a terminal illness. It also provides speech pathology, …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Fidelity Investments Inc:企業の戦略・SWOT・財務情報
    Fidelity Investments Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity Investments Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ARK Diagnostics Inc:企業の製品パイプライン分析
    Summary ARK Diagnostics Inc (ARK Diagnostics) is a developer, manufacturer and commercializer of in vitro diagnostic immunoassay products. The company's products include protease inhibitors, levetiracetam assay, topiramate assay, non-nucleoside reverse transcriptase inhibitors, gabapentin assay, lam …
  • CPC Corp:企業の戦略的SWOT分析
    CPC Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • MicroVention Inc:製品パイプライン分析
    Summary MicroVention Inc (MicroVention), a subsidiary of Terumo Corp is a medical device company that develops catheter based technologies for the endovascular treatment of peripheral and cerebral vascular diseases. The company offers products such as platinum coils, hydrogel coils, delivery and det …
  • Origin Energy Limited:企業の戦略・SWOT・財務分析
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tianjin Zhonghuan Semiconductor Co. Ltd. (002129):企業の財務・戦略的SWOT分析
    Tianjin Zhonghuan Semiconductor Co. Ltd. (002129) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university's faculty, …
  • Hokkaido Gas Co Ltd (9534):企業の財務・戦略的SWOT分析
    Summary Hokkaido Gas Co Ltd (Hokkaido Gas), a subsidiary of Kita Gas Group is an oil and gas company that distributes petroleum products. The company’s business activities include gas business, heat supply, power supply, purification and sale of gas by-products, and production and sale of gas applia …
  • Valero Energy Corporation (VLO)-石油・ガス分野:企業M&A・提携分析
    Summary Valero Energy Corporation (Valero) is a manufacturer and marketer of transportation fuels, petrochemical products and power. The company’s assets include petroleum refineries, ethanol plants, a wind farm and renewable diesel production from a joint venture. Its refineries produce gasoline, d …
  • Aecon Group Inc (ARE):企業の財務・戦略的SWOT分析
    Aecon Group Inc (ARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bailian Group Co Ltd:企業の戦略的SWOT分析
    Bailian Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Huaneng Power International, Inc.:企業の戦略・SWOT・財務情報
    Huaneng Power International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Huaneng Power International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Washington State University-製薬・医療分野:企業M&A・提携分析
    Summary Washington State University (WSU) is an educational university that provides educational and research programs. The university offers undergraduate, graduate, professional, international and online courses. It provides educational programs in the areas of agricultural, environmental and natu …
  • Invectys SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company provides product pipeline such as INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine UCPVax. It offers products such as a human telomerase peptide-based v …
  • Medicom Innovation Partner as:医療機器:M&Aディール及び事業提携情報
    Summary Medicom Innovation Partner a/s (Medicom), formerly Bang & Olufsen Medicom, a subsidiary of Phillips-Medisize Corp, is a medical device company that develops electronic-based drug delivery and connected health systems. The company offers services such as device strategy and direction, device …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆